Sanofi, GSK to provide 200 million Covid vaccine doses to WHO global immunization program
October 28, 2020 at 08:29 AM EDT
Sanofi and GSK's vaccine is further behind in clinical development than some of the front-runners like Pfizer, Moderna and AstraZeneca, which are all in late-stage trials.